Tetsuya Fujimori
Director/Miembro de la Junta en Cenegenics Japan KK .
Perfil
Tetsuya Fujimori is currently the Representative Director at Cenegenics Japan KK since 2020.
Prior to this, he worked as an Independent Outside Director at tella, Inc. Mr. Fujimori completed his undergraduate degree from Osaka City University in 1995.
Cargos activos de Tetsuya Fujimori
Empresas | Cargo | Inicio |
---|---|---|
Cenegenics Japan KK
Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan. | Director/Miembro de la Junta | 01/03/2020 |
Antiguos cargos conocidos de Tetsuya Fujimori.
Empresas | Cargo | Fin |
---|---|---|
TELLA, INC. | Director/Miembro de la Junta | - |
Formación de Tetsuya Fujimori.
Osaka City University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
tella, Inc.
tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
Cenegenics Japan KK
Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Tetsuya Fujimori